Sumitomo Mitsui Ds Asset Management Company, LTD Regeneron Pharmaceuticals, Inc. Transaction History
Sumitomo Mitsui Ds Asset Management Company, LTD
- $12.1 Billion
- Q3 2025
A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 14,241 shares of REGN stock, worth $9.88 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
14,241
Previous 14,266
0.18%
Holding current value
$9.88 Million
Previous $7.49 Million
6.92%
% of portfolio
0.07%
Previous 0.07%
Shares
33 transactions
Others Institutions Holding REGN
# of Institutions
1,465Shares Held
86.4MCall Options Held
2.42MPut Options Held
1.64M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...